EGFR polymorphisms drive lung cancer risk and survival disparities: a genotype-expression-outcome cohort study

PurposeTo investigate the correlation between single-nucleotide polymorphisms (SNPs) of the Epidermal growth factor receptor (EGFR) gene and its protein expression with susceptibility and survival prognosis of lung cancer (LC) patients.MethodsUsing SNP-scan high-throughput technology, the EGFR gene’...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao Zuo, Ziqiang Wang, Yi Liu, Jing Cheng, Dongli Yang, Yu Wang, Yongchao Qiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2025.1591539/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849322039603625984
author Chao Zuo
Ziqiang Wang
Yi Liu
Jing Cheng
Dongli Yang
Yu Wang
Yongchao Qiao
author_facet Chao Zuo
Ziqiang Wang
Yi Liu
Jing Cheng
Dongli Yang
Yu Wang
Yongchao Qiao
author_sort Chao Zuo
collection DOAJ
description PurposeTo investigate the correlation between single-nucleotide polymorphisms (SNPs) of the Epidermal growth factor receptor (EGFR) gene and its protein expression with susceptibility and survival prognosis of lung cancer (LC) patients.MethodsUsing SNP-scan high-throughput technology, the EGFR gene’s rs2227983, rs2293347, and rs884225 locations were analyzed in 300 LC patients and 150 healthy individuals. And small cell lung cancer (SCLC), lung adenocarcinoma (LUAD), and lung squamous carcinoma (LUSC) were subdivided into groups for lung cancer patients. Chi-square test and logistic regression analysis were used to assess the susceptibility of LC. The correlation between SNP haplotypes and LC risk was analyzed using the SHEsis website. KM curves and Cox regression were used to analyse the association between polymorphisms and survival prognosis of LC patients. Expression differences in protein levels were analyzed using immunohistochemistry.ResultsEGFR rs2293347 was associated with LUAD, LUSC, and SCLC susceptibility, and rs884225 was associated with LUAD susceptibility. Haplotype ATT was associated with LC and histological type LUAD and SCLC susceptibility. Meanwhile, rs2293347-TT and rs884225-TT were associated with worse prognosis, and rs2293347-TT was an independent risk factor for prognosis in patients with LC. Furthermore, tumor tissue EGFR protein levels were elevated in patients with both genotypes.ConclusionEGFR rs2293347 (pan-subtype) and rs884225 (LUAD-specific) polymorphisms increase LC risk through elevated protein expression, with rs2293347-TT conferring worse survival. These genotype-protein correlations highlight their dual role as susceptibility markers and prognostic predictors in precision oncology.
format Article
id doaj-art-5d5093ffa0b74509a5432bdf38b2dd6d
institution Kabale University
issn 1664-8021
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj-art-5d5093ffa0b74509a5432bdf38b2dd6d2025-08-20T03:49:33ZengFrontiers Media S.A.Frontiers in Genetics1664-80212025-05-011610.3389/fgene.2025.15915391591539EGFR polymorphisms drive lung cancer risk and survival disparities: a genotype-expression-outcome cohort studyChao Zuo0Ziqiang Wang1Yi Liu2Jing Cheng3Dongli Yang4Yu Wang5Yongchao Qiao6Department of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, ChinaResearch Center of Clinical Laboratory Science, Bengbu Medical University, Bengbu, Anhui, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, ChinaDepartment of Geriatrics, The First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, ChinaPurposeTo investigate the correlation between single-nucleotide polymorphisms (SNPs) of the Epidermal growth factor receptor (EGFR) gene and its protein expression with susceptibility and survival prognosis of lung cancer (LC) patients.MethodsUsing SNP-scan high-throughput technology, the EGFR gene’s rs2227983, rs2293347, and rs884225 locations were analyzed in 300 LC patients and 150 healthy individuals. And small cell lung cancer (SCLC), lung adenocarcinoma (LUAD), and lung squamous carcinoma (LUSC) were subdivided into groups for lung cancer patients. Chi-square test and logistic regression analysis were used to assess the susceptibility of LC. The correlation between SNP haplotypes and LC risk was analyzed using the SHEsis website. KM curves and Cox regression were used to analyse the association between polymorphisms and survival prognosis of LC patients. Expression differences in protein levels were analyzed using immunohistochemistry.ResultsEGFR rs2293347 was associated with LUAD, LUSC, and SCLC susceptibility, and rs884225 was associated with LUAD susceptibility. Haplotype ATT was associated with LC and histological type LUAD and SCLC susceptibility. Meanwhile, rs2293347-TT and rs884225-TT were associated with worse prognosis, and rs2293347-TT was an independent risk factor for prognosis in patients with LC. Furthermore, tumor tissue EGFR protein levels were elevated in patients with both genotypes.ConclusionEGFR rs2293347 (pan-subtype) and rs884225 (LUAD-specific) polymorphisms increase LC risk through elevated protein expression, with rs2293347-TT conferring worse survival. These genotype-protein correlations highlight their dual role as susceptibility markers and prognostic predictors in precision oncology.https://www.frontiersin.org/articles/10.3389/fgene.2025.1591539/fullEGFRpolymorphismlung cancersusceptibilityprognosis
spellingShingle Chao Zuo
Ziqiang Wang
Yi Liu
Jing Cheng
Dongli Yang
Yu Wang
Yongchao Qiao
EGFR polymorphisms drive lung cancer risk and survival disparities: a genotype-expression-outcome cohort study
Frontiers in Genetics
EGFR
polymorphism
lung cancer
susceptibility
prognosis
title EGFR polymorphisms drive lung cancer risk and survival disparities: a genotype-expression-outcome cohort study
title_full EGFR polymorphisms drive lung cancer risk and survival disparities: a genotype-expression-outcome cohort study
title_fullStr EGFR polymorphisms drive lung cancer risk and survival disparities: a genotype-expression-outcome cohort study
title_full_unstemmed EGFR polymorphisms drive lung cancer risk and survival disparities: a genotype-expression-outcome cohort study
title_short EGFR polymorphisms drive lung cancer risk and survival disparities: a genotype-expression-outcome cohort study
title_sort egfr polymorphisms drive lung cancer risk and survival disparities a genotype expression outcome cohort study
topic EGFR
polymorphism
lung cancer
susceptibility
prognosis
url https://www.frontiersin.org/articles/10.3389/fgene.2025.1591539/full
work_keys_str_mv AT chaozuo egfrpolymorphismsdrivelungcancerriskandsurvivaldisparitiesagenotypeexpressionoutcomecohortstudy
AT ziqiangwang egfrpolymorphismsdrivelungcancerriskandsurvivaldisparitiesagenotypeexpressionoutcomecohortstudy
AT yiliu egfrpolymorphismsdrivelungcancerriskandsurvivaldisparitiesagenotypeexpressionoutcomecohortstudy
AT jingcheng egfrpolymorphismsdrivelungcancerriskandsurvivaldisparitiesagenotypeexpressionoutcomecohortstudy
AT dongliyang egfrpolymorphismsdrivelungcancerriskandsurvivaldisparitiesagenotypeexpressionoutcomecohortstudy
AT yuwang egfrpolymorphismsdrivelungcancerriskandsurvivaldisparitiesagenotypeexpressionoutcomecohortstudy
AT yongchaoqiao egfrpolymorphismsdrivelungcancerriskandsurvivaldisparitiesagenotypeexpressionoutcomecohortstudy